Inverness Medical Innovations
Alere on Track to Launch HIV Viral Load Test Ex-US, File Isothermal Flu Assay with FDA in 2013
Alere President and CEO Ron Zwanziger last week provided investors with an update on the development timeline for a pair of point-of-care nucleic acid testing plartforms, the company's first molecular diagnostics products.
Health management-services and diagnostics firm Alere is developing a pair of nucleic acid testing platforms, representing the company's first major move into the molecular diagnostics space, according to recent company presentations.
AdvanDx to Offer Inverness' Test for MRSA Protein Detection
In clinical studies, the test demonstrated 97.1 percent positive agreement and 100 percent negative agreement with conventional methods of testing for MRSA, AdvanDx said.
Inverness to Distribute Molecular Detection's MRSA Assay
Inverness will sell the real-time PCR assay in Germany, Austria, and Switzerland.
Myconostica Gets OK to Sell Fungal Dx in Canada
The UK-based company also signed on Inverness Medical Canada to distribute its products in the country.
Nov 13, 2009